Terms: = Leukemia AND NUP214, ENSG00000126883, 8021, MGC104525, D9S46E, RP11-544A12_7, N214, CAIN, P35658, CAN AND Staging
180 results:
1. Secondary Analysis of the Rate of Second Primary Lung Cancer From Cancer and leukemia Group B 140503 (Alliance) Trial of Lobar Versus Sublobar Resection for T1aN0 Non-Small-Cell Lung Cancer.
Stinchcombe TE; Wang X; Damman B; Mentlick J; Landreneau R; Wigle D; Jones DR; Conti M; Ashrafi AS; Liberman M; de Perrot M; Mitchell JD; Keenan R; Bauer T; Miller D; Altorki N
J Clin Oncol; 2024 Apr; 42(10):1110-1113. PubMed ID: 38215351
[No Abstract] [Full Text] [Related]
2. [Effect of Circulating Plasma Cells on the Prognosis of Patients with Multiple Myeloma].
Li F; Gao YJ; Li SS; Xi YY; Yang XW; Su YH
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2023 Dec; 31(6):1771-1779. PubMed ID: 38071059
[TBL] [Abstract] [Full Text] [Related]
3. [Efficacy and safety of TBI+rATG-based conditioning regimen for haploidentical allogeneic hematopoietic stem cell transplantation in 11 cases of chemotherapy-resistant advanced peripheral T-cell lymphoma].
Xu R; Li S; Liu HX; Wei DL; Jiang Y; Wang JJ; Liu SS; Wang C; Zhu J
Zhonghua Xue Ye Xue Za Zhi; 2023 Jul; 44(7):578-581. PubMed ID: 37749039
[No Abstract] [Full Text] [Related]
4. Characteristics and outcome of infectious complications after autologous hematopoietic cell transplantation in multiple myeloma patients.
Jandial A; Lad D; Jain A; Khadwal A; Singh C; Prakash G; Suri V; Sreedharanunni S; Sachdeva MUS; Ray P; Varma N; Varma S; Malhotra P
Transpl Infect Dis; 2023 Oct; 25(5):e14123. PubMed ID: 37573150
[TBL] [Abstract] [Full Text] [Related]
5. Clinical Characteristics and Outcomes of Cancer Cases Among Syrian Refugees From Southern Turkey.
Kutluk T; Sahin B; Kirazli M; Ahmed F; Aydin S; Yesil Çinkir H; Sezgin G; Bayram I; Ebinç S; Isikdogan A; Sasmaz I; Okan V; Ilhan G; Ören AC; Akbayram S; Harputluoglu H; Ural C; Ayyildiz O; Aktas G; Uçar MA; Güvenç B; Köse D; Acipayam C; Güncan S; Erçolak V; Berber I; Akdeniz A; Akyay A; Üzel VH; Söker M; Sengelen M; Yalçin S; Sullivan R
JAMA Netw Open; 2023 May; 6(5):e2312903. PubMed ID: 37219908
[TBL] [Abstract] [Full Text] [Related]
6. Role of social status and social environment on net survival in patients with chronic lymphocytic leukemia: A high-resolution population-based study.
Delapierre B; Troussard X; Damaj G; Dejardin O; Tron L
Cancer Epidemiol; 2023 Feb; 82():102292. PubMed ID: 36410088
[TBL] [Abstract] [Full Text] [Related]
7. TNF-α-308A allele Carrier Induced to Development of Chronic Lymphocytic leukemia in Sudanese Population at Earlier Age.
Basabaeen AA; Abdelgader EA; Ahmed Babekir E; Abdelateif NM; Osman Abdelrahim S; Awadalkareem Omer AY; Altayeb OA; Fadul EA; Ibrahim IK
Asian Pac J Cancer Prev; 2022 Oct; 23(10):3449-3455. PubMed ID: 36308371
[TBL] [Abstract] [Full Text] [Related]
8. [Mid-term efficacy of China Net Childhood Lymphoma-mature B-cell lymphoma 2017 regimen in the treatment of pediatric Burkitt lymphoma].
Zhang M; Wu P; Duan YL; Jin L; Yang J; Huang S; Liu Y; Hu B; Zhai XW; Wang HS; Fu Y; Li F; Yang XM; Liu AS; Qin S; Yuan XJ; Dong YS; Liu W; Zhou JW; Zhang LP; Jia YP; Wang J; Qu LJ; Dai YP; Guan GT; Sun LR; Jiang J; Liu R; Jin RM; Wang ZJ; Wang XG; Zhang BX; Chen KL; Zhuang SQ; Zhang J; Zhou CJ; Gao ZF; Zheng MC; Zhang Y
Zhonghua Er Ke Za Zhi; 2022 Oct; 60(10):1011-1018. PubMed ID: 36207847
[No Abstract] [Full Text] [Related]
9. Interleukin-10-1082A>G (rs1800896) Single Nucleotide Polymorphism is Not a Risk Factor of Chronic Lymphocytic leukemia in Sudanese Population.
Basabaeen AA; Abdelgader EA; Ahmed EB; Abdelateif NM; Osman Abdelrahim S; Sharif OM; Altayeb OA; Fadul EA; Osman Ibrahim I
Asian Pac J Cancer Prev; 2022 Sep; 23(9):3229-3235. PubMed ID: 36172689
[TBL] [Abstract] [Full Text] [Related]
10. Immune status does not independently influence cutaneous squamous cell carcinoma metastasis and death when stratified by tumor stage: A dual-center retrospective cohort analysis of primary N0 disease.
O'Connor DM; Murad F; Danesh MJ; Butler W; Smile TD; Ilori EO; Gastman BR; Vidimos A; Waldman AB; Schmults CD; Koyfman S; Ruiz ES
J Am Acad Dermatol; 2022 Dec; 87(6):1295-1302. PubMed ID: 36063987
[TBL] [Abstract] [Full Text] [Related]
11. Melflufen or pomalidomide plus dexamethasone for patients with multiple myeloma refractory to lenalidomide (OCEAN): a randomised, head-to-head, open-label, phase 3 study.
Schjesvold FH; Dimopoulos MA; Delimpasi S; Robak P; Coriu D; Legiec W; Pour L; Špička I; Masszi T; Doronin V; Minarik J; Salogub G; Alekseeva Y; Lazzaro A; Maisnar V; Mikala G; Rosiñol L; Liberati AM; Symeonidis A; Moody V; Thuresson M; Byrne C; Harmenberg J; Bakker NA; Hájek R; Mateos MV; Richardson PG; Sonneveld P;
Lancet Haematol; 2022 Feb; 9(2):e98-e110. PubMed ID: 35032434
[TBL] [Abstract] [Full Text] [Related]
12. Outcomes of children and young adults with T-cell acute lymphoblastic leukemia/lymphoma who present in critical status.
Wayne NJ; Li Y; Chung P; Coffan K; Rheingold SR
Pediatr Blood Cancer; 2022 Apr; 69(4):e29457. PubMed ID: 34997812
[TBL] [Abstract] [Full Text] [Related]
13. Prognostic gene expression analysis in a retrospective, multinational cohort of 155 multiple myeloma patients treated outside clinical trials.
Chen YT; Valent ET; van Beers EH; Kuiper R; Oliva S; Haferlach T; Chng WJ; van Vliet MH; Sonneveld P; Larocca A
Int J Lab Hematol; 2022 Feb; 44(1):127-134. PubMed ID: 34448362
[TBL] [Abstract] [Full Text] [Related]
14. Bortezomib, lenalidomide, and dexamethasone with or without elotuzumab in patients with untreated, high-risk multiple myeloma (SWOG-1211): primary analysis of a randomised, phase 2 trial.
Usmani SZ; Hoering A; Ailawadhi S; Sexton R; Lipe B; Hita SF; Valent J; Rosenzweig M; Zonder JA; Dhodapkar M; Callander N; Zimmerman T; Voorhees PM; Durie B; Rajkumar SV; Richardson PG; Orlowski RZ;
Lancet Haematol; 2021 Jan; 8(1):e45-e54. PubMed ID: 33357482
[TBL] [Abstract] [Full Text] [Related]
15. Increasing incidence of cancer and stage migration towards advanced disease in children and young adolescents in the Netherlands, 1990-2017.
Reedijk AMJ; Kremer LC; Visser O; Lemmens V; Pieters R; Coebergh JWW; Karim-Kos HE
Eur J Cancer; 2020 Jul; 134():115-126. PubMed ID: 32521425
[TBL] [Abstract] [Full Text] [Related]
16. [Autologous hematopoietic stem cell transplantation treatment for T cell lymphoblastic lymphoma].
Wang P; Li CX; Zhang Y; Chen J; Chen XC; Yang D; Zhou J; Zong XP; Yang Z; Wu M; Yang MZ; Song YQ; Zhu J; Wu DP
Zhonghua Xue Ye Xue Za Zhi; 2020 Mar; 41(3):198-203. PubMed ID: 32311888
[No Abstract] [Full Text] [Related]
17. [Clinicopathological features of myeloid sarcoma and DLBCL in the breast: a comparative study].
Chen DB; Zhang H; Kong FZ; Jiang Q; Fang XZ; Shen DH; Kan X
Zhonghua Bing Li Xue Za Zhi; 2020 Mar; 49(3):250-255. PubMed ID: 32187897
[No Abstract] [Full Text] [Related]
18. [Clinical analysis of a modified LMB89 Group C regimen in the treatment of pediatric high-risk Burkitt lymphoma].
Zhang M; Jin L; Yang J; Duan YL; Huang S; Zhou CJ; Zhang YH
Zhonghua Xue Ye Xue Za Zhi; 2019 Aug; 40(8):633-638. PubMed ID: 31495128
[No Abstract] [Full Text] [Related]
19. Prevalence of Occult Peribronchial N1 Nodal Metastasis in Peripheral Clinical N0 Small (≤2 cm) Non-Small Cell Lung Cancer.
Robinson EM; Ilonen IK; Tan KS; Plodkowski AJ; Bott M; Bains MS; Adusumilli PS; Park BJ; Rusch VW; Jones DR; Huang J
Ann Thorac Surg; 2020 Jan; 109(1):270-276. PubMed ID: 31479639
[TBL] [Abstract] [Full Text] [Related]
20. [Clinical Features and Prognosis of 35 Children with Burkitt Lymphoma/leukemia].
Zheng YZ; LE SH; Zheng H; Hua XL; Chen ZS; Zheng L; Chen C; Li M; Cai CX; Yang JH; Chen YQ; Gao QL; Chen YY; Li J; Hu JD
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2019 Aug; 27(4):1123-1130. PubMed ID: 31418367
[TBL] [Abstract] [Full Text] [Related]
[Next]
